Perspective Therapeutics Inc. (CATX)
NYSE · Healthcare
Perspective Therapeutics Inc. Shareholder Equity 2020–2025
Perspective Therapeutics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Perspective Therapeutics Inc. shareholder equity as of December 31, 2025: 207.0M, a 28.77% decrease year-over-year.
- Perspective Therapeutics Inc. shareholder equity for 2025 were 207.0M, a 28.77% decrease from 2024.
- Perspective Therapeutics Inc. shareholder equity for 2024 were 290.7M, a 286.63% increase from 2023.
- Perspective Therapeutics Inc. shareholder equity for 2023 were 75.2M, a 22.69% increase from 2022.
- Perspective Therapeutics Inc. shareholder equity for 2022 were 61.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Perspective Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $207 |
| 2024 | $291 |
| 2023 | $75 |
| 2022 | $61 |
| 2021 | $67 |
| 2020 | $6 |
Perspective Therapeutics Inc. Shareholder Equity — FAQ
Perspective Therapeutics Inc. (CATX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CATX's shareholder equity history?
The chart and table above show Perspective Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.